263 related articles for article (PubMed ID: 32229191)
1. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
[TBL] [Abstract][Full Text] [Related]
2. Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer.
Liu K; Gao H; Wang Q; Wang L; Zhang B; Han Z; Chen X; Han M; Gao M
Cancer Sci; 2018 May; 109(5):1369-1381. PubMed ID: 29575334
[TBL] [Abstract][Full Text] [Related]
3. Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect.
Zhang M; Liu T; Sun H; Weng W; Zhang Q; Liu C; Han Y; Sheng W
Cancer Sci; 2018 May; 109(5):1468-1479. PubMed ID: 29516572
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
5. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
[TBL] [Abstract][Full Text] [Related]
6. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
7. TAK1-dependent signaling requires functional interaction with TAB2/TAB3.
Besse A; Lamothe B; Campos AD; Webster WK; Maddineni U; Lin SC; Wu H; Darnay BG
J Biol Chem; 2007 Feb; 282(6):3918-28. PubMed ID: 17158449
[TBL] [Abstract][Full Text] [Related]
8. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
9. Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex.
Mendoza H; Campbell DG; Burness K; Hastie J; Ronkina N; Shim JH; Arthur JS; Davis RJ; Gaestel M; Johnson GL; Ghosh S; Cohen P
Biochem J; 2008 Feb; 409(3):711-22. PubMed ID: 18021073
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and immunomodulatory effects of PIM1 in colorectal carcinoma.
Zhou Y; Zhou Y; Liu S; Wang J; Ji R; Yan X
J BUON; 2021; 26(2):513-520. PubMed ID: 34077000
[TBL] [Abstract][Full Text] [Related]
11. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway.
Du W; Hong J; Wang YC; Zhang YJ; Wang P; Su WY; Lin YW; Lu R; Zou WP; Xiong H; Fang JY
J Cell Mol Med; 2012 Aug; 16(8):1878-88. PubMed ID: 22050790
[TBL] [Abstract][Full Text] [Related]
13. TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex.
Luo C; Yuan R; Chen L; Zhou W; Shen W; Qiu Y; Shao J; Yan J; Shao J
Oncotarget; 2017 Dec; 8(63):106565-106576. PubMed ID: 29290971
[TBL] [Abstract][Full Text] [Related]
14. Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.
Chen L; Fu L; Kong X; Xu J; Wang Z; Ma X; Akiyama Y; Chen Y; Fang J
Br J Cancer; 2014 Feb; 110(4):1014-26. PubMed ID: 24473398
[TBL] [Abstract][Full Text] [Related]
15. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
[TBL] [Abstract][Full Text] [Related]
16. LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo.
Zhou J; Zheng B; Ji J; Shen F; Min H; Liu B; Wu J; Zhang S
Tumour Biol; 2015 May; 36(5):3301-8. PubMed ID: 25524577
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
18. RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.
Meloche J; Paulin R; Courboulin A; Lambert C; Barrier M; Bonnet P; Bisserier M; Roy M; Sussman MA; Agharazii M; Bonnet S
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2114-24. PubMed ID: 21680901
[TBL] [Abstract][Full Text] [Related]
19. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
20. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
